317 related articles for article (PubMed ID: 26785611)
1. GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction.
Li Z; Cheng L; Liang H; Duan W; Hu J; Zhi W; Yang J; Liu Z; Zhao M; Liu J
Eur J Cell Biol; 2016 Feb; 95(2):100-13. PubMed ID: 26785611
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice.
Zhang Y; Liu J; Tian XY; Wong WT; Chen Y; Wang L; Luo J; Cheang WS; Lau CW; Kwan KM; Wang N; Yao X; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):152-9. PubMed ID: 24202302
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled estrogen receptor activation improves contractile and diastolic functions in rat renal interlobular artery to protect against renal ischemia reperfusion injury.
Chang Y; Han Z; Zhang Y; Zhou Y; Feng Z; Chen L; Li X; Li L; Si JQ
Biomed Pharmacother; 2019 Apr; 112():108666. PubMed ID: 30784936
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.
Meyer MR; Fredette NC; Barton M; Prossnitz ER
J Endocrinol; 2015 Oct; 227(1):61-9. PubMed ID: 26303299
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.
Gros R; Ding Q; Liu B; Chorazyczewski J; Feldman RD
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C532-40. PubMed ID: 23283935
[TBL] [Abstract][Full Text] [Related]
6. Role of GPER in estrogen-dependent nitric oxide formation and vasodilation.
Fredette NC; Meyer MR; Prossnitz ER
J Steroid Biochem Mol Biol; 2018 Feb; 176():65-72. PubMed ID: 28529128
[TBL] [Abstract][Full Text] [Related]
7. Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal women.
Arefin S; Simoncini T; Wieland R; Hammarqvist F; Spina S; Goglia L; Kublickiene K
Maturitas; 2014 Jun; 78(2):123-30. PubMed ID: 24796498
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the participation of endothelial mediators and signaling pathways involved in the vasodilator effect of a selective GPER agonist in resistance arteries of gonadectomized Wistar rats.
Peixoto P; Vieira-Alves I; Couto GK; Lemos VS; Rossoni LV; Bissoli NS; Santos RLD
Life Sci; 2022 Nov; 308():120917. PubMed ID: 36044974
[TBL] [Abstract][Full Text] [Related]
9. Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA.
Yu X; Zhang Q; Zhao Y; Schwarz BJ; Stallone JN; Heaps CL; Han G
PLoS One; 2017; 12(3):e0173085. PubMed ID: 28278256
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate improves vascular endothelial function in diabetic mice.
Xin R; An D; Li Y; Fu J; Huang F; Zhu Q
Biomed Pharmacother; 2019 Apr; 112():108722. PubMed ID: 30970521
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated PKM2 regulates endothelium-dependent vasodilation in diabetes.
Lu B; Tang L; Li L; Zhou X; Leng Y; Quan C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):663-670. PubMed ID: 37539568
[TBL] [Abstract][Full Text] [Related]
12. G protein coupled estrogen receptor attenuates mechanical stress-mediated apoptosis of chondrocyte in osteoarthritis via suppression of Piezo1.
Sun Y; Leng P; Guo P; Gao H; Liu Y; Li C; Li Z; Zhang H
Mol Med; 2021 Aug; 27(1):96. PubMed ID: 34454425
[TBL] [Abstract][Full Text] [Related]
13. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
[TBL] [Abstract][Full Text] [Related]
15. Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction.
Meyer MR; Amann K; Field AS; Hu C; Hathaway HJ; Kanagy NL; Walker MK; Barton M; Prossnitz ER
Hypertension; 2012 Feb; 59(2):507-12. PubMed ID: 22203741
[TBL] [Abstract][Full Text] [Related]
16. Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction.
Kim SH; Kim SH; Choi M; Lee Y; Kim YO; Ahn DS; Kim YH; Kang ES; Lee EJ; Jung M; Cho JW; Williams DR; Lee HC
Cardiovasc Res; 2010 Sep; 87(4):713-22. PubMed ID: 20299332
[TBL] [Abstract][Full Text] [Related]
17. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
18. Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation.
El-Remessy AB; Tawfik HE; Matragoon S; Pillai B; Caldwell RB; Caldwell RW
Exp Diabetes Res; 2010; 2010():247861. PubMed ID: 21052489
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
20. Icariin attenuates vascular endothelial dysfunction by inhibiting inflammation through GPER/Sirt1/HMGB1 signaling pathway in type 1 diabetic rats.
Yao W; Tao R; Wang K; Ding X
Chin J Nat Med; 2024 Apr; 22(4):293-306. PubMed ID: 38658093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
